Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Events
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Roger Perlmutter
Biotech
Eikon snaps up clinical pipeline thanks to 'buyer's market'
Eikon Therapeutics is spending some of the more than $600 million its raised on a basket of assets, including three clinical-stage candidates.
Max Bayer
Jun 1, 2023 8:00am
Reuniting the band: Former Merck CEO follows colleagues to Eikon
Mar 31, 2022 10:13am
Merck's CMO follows Roger Perlmutter to Eikon
Mar 23, 2022 11:38am
Perlmutter named CEO of biotech pursuing undruggable targets
May 5, 2021 6:30am
7-year itch: Perlmutter exits as Merck R&D lead
Oct 2, 2020 8:30am
Janssen drops the BACE as Alzheimer’s drug joins fail list
May 18, 2018 9:25am